<Suppliers Price>

Butyrophenone, p-fluoro-4-(1,2,3,6-tetrahydro-1,3-dimethyl-2-oxo-6-thionopurin-8-ylthio)-

Names

[ CAS No. ]:
6505-98-2

[ Name ]:
Butyrophenone, p-fluoro-4-(1,2,3,6-tetrahydro-1,3-dimethyl-2-oxo-6-thionopurin-8-ylthio)-

Chemical & Physical Properties

[ Density]:
1.48g/cm3

[ Boiling Point ]:
624.6ºC at 760 mmHg

[ Molecular Formula ]:
C17H17FN4O2S2

[ Molecular Weight ]:
392.47100

[ Flash Point ]:
331.6ºC

[ Exact Mass ]:
392.07800

[ PSA ]:
130.07000

[ LogP ]:
3.22390

[ Index of Refraction ]:
1.693

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
EU4745000
CHEMICAL NAME :
Butyrophenone, p-fluoro-4-(1,2,3,6-tetrahydro-1,3-dimethyl-2-oxo-6-t hionopurin-8-ylthio)-
CAS REGISTRY NUMBER :
6505-98-2
LAST UPDATED :
199612
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C17-H17-F-N4-O2-S2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
56 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CSLNX* U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) Volume(issue)/page/year: NX#04454

Safety Information

[ RIDADR ]:
NONH for all modes of transport

Articles

A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.

J. Biol. Chem. 285(53) , 41863-73, (2010)

The mechanisms responsible for 17β-estradiol (E(2))-stimulated breast cancer growth and development of resistance to tamoxifen and other estrogen receptor α (ERα) antagonists are not fully understood....

A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.

J. Biol. Chem. 283 , 12819-12830, (2008)

Estrogen receptor alpha (ERalpha) plays an important role in several human cancers. Most current ERalpha antagonists bind in the receptor ligand binding pocket and compete for binding with estrogenic ...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.